We have summarized how steroid hormones (E2 and PR) and growth factors (EGF/ERBB1 and HER2) can induce the transcription of PRLR, thereby increasing its expression in breast cancer cells and promoting cell proliferation. Here, ERBB2 is linked to breast cancer.